🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
By chance the investigators found that iv. silibinin has a potent antiviral...
Status
Completed
Location
Medical University of Vienna
Start Date
2007-10
Trial ID
NCT00684268
Chronic Hepatitis C Virus (HCV) infection is a major cause of liver cirrhos...
Status
Unknown
Location
Service d'Hépatogastroentérologie, NHC1, place de l'hôpital
Start Date
2013-05
Trial ID
NCT01835938
Treatments Being Tested
SIM0308-302 is a multicenter, randomized, double-blind, placebo-controlled ...
Status
Unknown
Location
Multiple Locations
Start Date
2023-12-28
Trial ID
NCT06176781
Treatments Being Tested
1. This study aims to compare the efficacy of empirical vonoprazan-based th...
Status
Not Yet Recruiting
Location
National Taiwan University Hospital
Start Date
2025-08-18
Trial ID
NCT07130253
Treatments Being Tested
The goal of this clinical trial is to learn if a new treatment called Achro...
Status
Recruiting
Location
University of California San Diego (UCSD)
Start Date
2026-08-01
Trial ID
NCT07275905
Treatments Being Tested
This is a 4-week sequential drug interaction study to measure the effects o...
Status
Completed
Location
Johns Hopkins University
Start Date
2010-09-28
Trial ID
NCT01136928
Treatments Being Tested
This Phase II, single arm study evaluates a PSA-response-adapted approach t...
Status
Recruiting
Location
UT Southwestern Medical Center-Dallas
Start Date
2025-11-14
Trial ID
NCT07313241
Treatments Being Tested
This is a randomized, double-blind, placebo-controlled, multiple-ascending ...
Status
Terminated
Location
California Clinical Trials
Start Date
2013-01
Trial ID
NCT01803945
This was a randomized, placebo-controlled, double-blind, six-sequence, thre...
Status
Completed
Location
Novartis Investigative Site
Start Date
2017-06-26
Trial ID
NCT03108027
This study is to evaluate the safety and tolerability of vorinostat in comb...
Status
Completed
Location
Multiple Locations
Start Date
2007-06
Trial ID
NCT00479232
Treatments Being Tested